CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS, Placebo to Clostridium Botulinum neurotoxin type A (150 kD)
M602011085
Phase 3 small_molecule active
Quick answer
CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS, Placebo to Clostridium Botulinum neurotoxin type A (150 kD) for Episodic migraine is a Phase 3 program (small_molecule) at Merz Therapeutics GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merz Therapeutics GmbH
- Indication
- Episodic migraine
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active